Updates from Developmental Medicine & Child Neurology – September 2021
Please see below for the latest updates from DMCN and highlights from our latest issue. This month the spotlight is on cerebral palsy.
In this issue we have highlights from DMCN on the science behind cannabis-based medicinal products in paediatric epilepsies and a comprehensive look at the risk of Alzheimer disease and related dementia among adults with cerebral palsy.
Robert Akins and Benjamin Shrader discuss “Transcriptional analysis of muscle tissue and isolated satellite cells in spastic cerebral palsy” in this month’s podcast spotlight, and in our book programme we are currently offering 15% off our titles on cerebral palsy.
Key papers published this month
Epilepsy and cannabis: so near, yet so far
In this invited review, Kirkpatrick and O’Callaghan explore the science behind cannabis-based medicinal products in paediatric epilepsies and highlight the areas that warrant further research.
Risk of early- and late-onset Alzheimer disease and related dementia in adults with cerebral palsy
This comprehensive article examines the risk of Alzheimer disease and related dementia among adults with cerebral palsy. It finds preventative and/or therapeutic services should be used to reduce the risk of Alzheimer disease and related dementia in this population.
Physical therapy with hippotherapy compared to physical therapy alone in children with cerebral palsy: systematic review and meta-analysis
This systematic review by Santos de Assis et al. compares the effects of physical therapy with hippotherapy versus physical therapy alone on the gross motor function of children and adolescents with cerebral palsy. From the studies they assessed, the addition of hippotherapy did not led to significant improvements.
Robert Akins and Benjamin Shrader discuss Transcriptional analysis of muscle tissue and isolated satellite cells in spastic cerebral palsy.
Check out more podcasts on the DMCN YouTube channel.